similar disease free survival with sublobar resection we must do more
Published 11 months ago • 150 plays • Length 6:27Download video MP4
Download video MP3
Similar videos
-
5:10
disease-free survival: endpoint for adjuvant therapy for cancer?
-
40:21
extending horizons with immune checkpoint inhibitors in small cell lung cancer: 2022 perspectives
-
1:06
disease-free survival vs. progression-free survival in cancer studies
-
36:16
early-stage resectable non-small cell lung cancer: navigating a changing treatment landscape
-
22:41
s1 episode 5: small cell lung cancer: what are the first-line and second-line treatment options?
-
2:53
latest technology in detecting and treating lung cancer - dr. sharad dass
-
28:56
survival analysis-progression free survival (pfs) - real world evidence. visit: www.swananalytics.in
-
24:51
inside story - could superbugs become deadlier than cancer?
-
26:27
s2 episode 4: the evolution of nonoperative rectal cancer management
-
35:18
early-stage resectable non-small cell lung cancer: sharing patient perspectives
-
20:16
updates on immune modulators in lung cancer: have we met the need?
-
36:51
immunotherapy and the covid-19 pandemic: addressing clinical case challenges in lung cancer
-
23:52
s1 episode 2: biomarkers and targeted therapies for lung cancer
-
35:53
managing early-stage resectable non-small cell lung cancer: through the eyes of the patient and t...
-
15:57
satoshi shiono | better survival with lobectomy vs sublobar resection in patients with hypermeta...
-
5:41
new c word cure should be the goal for patients with lung cancer
-
15:34
what's new in her2? evaluating the evidence in non-small cell lung cancer
-
5:45
postop rt: meaningful survival improvement in n2 lung cancer
-
33:18
ret inhibitors for ret-altered non-small cell lung cancer: identification, treatment, and practic...
-
29:52
s1 episode 3: immunotherapy and lung cancer treatment
-
59:05
oncochallenge in locally advanced head and neck cancer: exploring new directions